Tag Archives: Pharmaceutical Patent

A series of recent Supreme Court cases have left the state of patent law in flux, and what happens next is really anyone’s guess. The Court’s decisions in Bilski v. Kappos, Mayo Collaborative Services v. Prometheus Laboratories, Inc. and Association For Molecular Pathology v. Myriad Genetics, Inc. have resulted in scores of patent applications being rejected […]